These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 15345287

  • 1. Mutant N-ras preferentially drives human CD34+ hematopoietic progenitor cells into myeloid differentiation and proliferation both in vitro and in the NOD/SCID mouse.
    Shen SW, Dolnikov A, Passioura T, Millington M, Wotherspoon S, Rice A, MacKenzie KL, Symonds G.
    Exp Hematol; 2004 Sep; 32(9):852-60. PubMed ID: 15345287
    [Abstract] [Full Text] [Related]

  • 2. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
    Shen S, Passioura T, Symonds G, Dolnikov A.
    Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
    [Abstract] [Full Text] [Related]

  • 3. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
    Kikuchi J, Mimuro J, Ogata K, Tabata T, Ueda Y, Ishiwata A, Kimura K, Takano K, Madoiwa S, Mizukami H, Hanazono Y, Kume A, Hasegawa M, Ozawa K, Sakata Y.
    J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
    [Abstract] [Full Text] [Related]

  • 4. Efficiency of transgenic T cell generation from gene-marked cultured human CD34+ cord blood cells is determined by their maturity and the cytokines present in the culture medium.
    Verhasselt B, Naessens E, De Smedt M, Plum J.
    Gene Ther; 2000 May; 7(10):830-6. PubMed ID: 10845720
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhancement of proliferation and differentiation of erythroid progenitors by co-transduction of erythropoietin receptor and H-ras cDNAS into single CD34(3+) cord blood cells.
    Lu L, Ge Y, Li ZH, Dai MS, Broxmeyer HE.
    Bone Marrow Transplant; 2000 Oct; 26(8):817-22. PubMed ID: 11081379
    [Abstract] [Full Text] [Related]

  • 8. Cytokine-pretreatment of CD34(+) cord blood stem cells in vitro reduces long-term cell engraftment in NOD/SCID mice.
    Wulf-Goldenberg A, Eckert K, Fichtner I.
    Eur J Cell Biol; 2008 Feb; 87(2):69-80. PubMed ID: 17931741
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Involvement of H-ras in erythroid differentiation of TF1 and human umbilical cord blood CD34 cells.
    Ge Y, Li ZH, Marshall MS, Broxmeyer HE, Lu L.
    Blood Cells Mol Dis; 1998 Jun; 24(2):124-36; discussion 137. PubMed ID: 9628849
    [Abstract] [Full Text] [Related]

  • 12. Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study.
    Berger M, Frairia R, Piacibello W, Sanavio F, Palmero A, Venturi C, Pignochino Y, Berta L, Madon E, Aglietta M, Fagioli F.
    Exp Hematol; 2005 Nov; 33(11):1371-87. PubMed ID: 16263422
    [Abstract] [Full Text] [Related]

  • 13. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
    Lavenu-Bombled C, Izac B, Legrand F, Cambot M, Vigier A, Massé JM, Dubart-Kupperschmitt A.
    Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
    Fei XM, Wu YJ, Chang Z, Miao KR, Tang YH, Zhou XY, Wang LX, Pan QQ, Wang CY.
    Cytotherapy; 2007 Jun; 9(4):338-47. PubMed ID: 17573609
    [Abstract] [Full Text] [Related]

  • 16. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
    Zheng Y, Sun A, Han ZC.
    Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Differential study on the in vivo homing potential of human hematopoietic stem/progenitor cells from different sources in xenotransplanted NOD/SCID mouse model].
    Yang Z, Lu SH, Li YH, Liu B, Wang HJ, Jia HR, Zheng YZ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):391-5. PubMed ID: 17939405
    [Abstract] [Full Text] [Related]

  • 20. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.
    Madlambayan GJ, Rogers I, Purpura KA, Ito C, Yu M, Kirouac D, Casper RF, Zandstra PW.
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1020-30. PubMed ID: 17084368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.